title: Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome.
abstract: Several abnormalities have been demonstrated in the intestines of patients with irritable bowel syndrome (IBS); however, the endocrine cells in the stomachs of these patients have not been investigated. The aim of the present study was to determine whether there are any abnormalities in the endocrine cells of the stomachs of patients with IBS using chromogranin A (CgA) as a common marker for endocrine cells. A total of 76 patients were included, of which 26 presented with diarrhoea as the predominant symptom (IBS‑D), 21 exhibited diarrhoea and constipation (IBS‑M), and 29 experienced constipation as the predominant symptom (IBS‑C). In addition, 59 healthy volunteers were recruited as controls. The patients and the controls underwent gastroscopy, and biopsy samples were obtained from the antrum and corpus of the stomach. The biopsy samples were immunostained and the CgA‑positive cell density and the intensity of the CgA immunoreactivity were determined. The CgA‑positive cell densities in the antra of patients with IBS‑M were significantly reduced relative to the controls (P<0.01), while the densities were significantly increased in the antra and corpora of the IBS‑C patients (P<0.01 and P<0.001 respectively). The intensities of CgA immunoreactivity did not differ significantly between the IBS patients and the controls. The abnormalities in the densities of endocrine cells were not associated with concomitant changes in the intensities of immunoreactivity; this may indicate unchanged synthesis and/or release of the hormones. In conclusion, the difference in the density of endocrine cells among the IBS subtypes may reflect a role of these cells in the differential symptomologies of these subtypes.
authors.affiliation: Section for Gastroenterology, Department of Medicine, Stord Helse-Fonna Hospital, Stord 54 09, Norway.
authors.forename: Magdy
authors.initials: M
authors.lastname: El-Salhy
authors.affiliation: Section for Gastroenterology, Department of Clinical Medicine, University of Bergen, Bergen 5020, Norway.
authors.forename: Odd Helge
authors.initials: OH
authors.lastname: Gilja
authors.affiliation: Section for Gastroenterology, Department of Clinical Medicine, University of Bergen, Bergen 5020, Norway.
authors.forename: Trygve
authors.initials: T
authors.lastname: Hausken
mesh_terms: D000293:Adolescent; D000328:Adult; D053379:Chromogranin A / Q000378:metabolism*; D004386:Duodenum / Q000378:metabolism / Q000473:pathology; D055098:Endocrine Cells / Q000378:metabolism*; D004947:Esophagus / Q000378:metabolism / Q000473:pathology; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism; D005773:Gastroscopy; D006801:Humans; D007150:Immunohistochemistry; D043183:Irritable Bowel Syndrome / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D013270:Stomach / Q000473:pathology*; D055815:Young Adult
chemical_list: D053379:Chromogranin A
references.citation: Neurogastroenterol Motil. 2006 Jul;18(7):539-46
references.pmid: 16771769
references.citation: Yonsei Med J. 2010 Jan;51(1):45-51
references.pmid: 20046513
references.citation: Scand J Gastroenterol. 2010 Dec;45(12):1435-9
references.pmid: 20602602
references.citation: Gut. 2000 Dec;47(6):804-11
references.pmid: 11076879
references.citation: Lancet. 1987 Apr 25;1(8539):963-5
references.pmid: 2882351
references.citation: Gastroenterology. 2006 Apr;130(5):1480-91
references.pmid: 16678561
references.citation: Front Biosci (Elite Ed). 2012 Jun 01;4:2783-800
references.pmid: 22652678
references.citation: Endocr Rev. 1991 May;12(2):181-7
references.pmid: 2070778
references.citation: Dig Dis Sci. 2010 Dec;55(12):3508-13
references.pmid: 20300845
references.citation: Gut. 2007 Dec;56(12):1770-98
references.pmid: 17488783
references.citation: J Gastroenterol Hepatol. 2008 Nov;23(11):1689-94
references.pmid: 19120860
references.citation: Gastroenterol Clin North Am. 2011 Mar;40(1):121-39
references.pmid: 21333904
references.citation: Int J Mol Med. 2009 Jun;23(6):703-7
references.pmid: 19424595
references.citation: Dig Dis Sci. 2012 Apr;57(4):873-8
references.pmid: 22057239
references.citation: Int J Mol Med. 2012 May;29(5):723-31
references.pmid: 22366773
references.citation: Regul Pept. 2014 Jan 10;188:60-5
references.pmid: 24316398
references.citation: Aliment Pharmacol Ther. 2010 Apr;31(8):883-91
references.pmid: 20132151
references.citation: Mol Med Rep. 2013 Apr;7(4):1241-4
references.pmid: 23426642
references.citation: Br J Cancer. 2011 Mar 29;104(7):1202-6
references.pmid: 21343936
references.citation: Mol Med Rep. 2012 Dec;6(6):1223-5
references.pmid: 22992886
references.citation: N Engl J Med. 2003 Mar 20;348(12):1134-49
references.pmid: 12646671
references.citation: Gut. 2004 Aug;53(8):1096-101
references.pmid: 15247174
references.citation: Ups J Med Sci. 1997;102(3):175-84
references.pmid: 9556842
references.citation: Gastroenterology. 2004 Jun;126(7):1657-64
references.pmid: 15188158
references.citation: Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;58(2):95-121
references.pmid: 2575822
references.citation: Gastroenterology. 2003 Dec;125(6):1651-9
references.pmid: 14724817
references.citation: Clin Gastroenterol Hepatol. 2005 Apr;3(4):349-57
references.pmid: 15822040
references.citation: World J Gastroenterol. 2007 Dec 7;13(45):6041-7
references.pmid: 18023097
references.citation: Int J Mol Med. 2009 Dec;24(6):727-32
references.pmid: 19885611
references.citation: Dig Dis Sci. 1993 Sep;38(9):1569-80
references.pmid: 8359066